HRP20090158T1 - Substituted pyrroles, compositions containing same, method for making same and use thereof - Google Patents

Substituted pyrroles, compositions containing same, method for making same and use thereof

Info

Publication number
HRP20090158T1
HRP20090158T1 HR20090158T HRP20090158T HRP20090158T1 HR P20090158 T1 HRP20090158 T1 HR P20090158T1 HR 20090158 T HR20090158 T HR 20090158T HR P20090158 T HRP20090158 T HR P20090158T HR P20090158 T1 HRP20090158 T1 HR P20090158T1
Authority
HR
Croatia
Prior art keywords
substituted
same
compositions containing
independently selected
substituted pyrroles
Prior art date
Application number
HR20090158T
Other languages
Croatian (hr)
Inventor
Ronan Baptiste
Tabart Michel
Souaille Catherine
Viviani Fabrice
Bacque Eric
Lettalec Jean-Philippe
Desmazeau Pascal
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090158(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20090158T1 publication Critical patent/HRP20090158T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Produkt koji odgovara sljedećoj formuli (I), ,u kojoj: A-1-Ar je: gdje svaki X1, X2, X3 i X4 je neovisno odabran između N i CH, igdje A je odabran između po izboru supstituiranog fenila, pirazolila i izoksazolila; L je NH-CO-NH; Ra je H; R1 je H; R2 i R5 su neovisno odabrani iz grupe koja se sastoji od: H, halogena, R'2, OR'2, NHR'2, NHCOR'2, NHCONHR'2, NHSO2R'2, u kojoj svaki R'2, R'3 i R'4 je neovisno odabran iz grupe koja se sastoji od H, alkila, alkenila, alkinila, arila, heteroarila, cikloalkila, heterocikloalkila, supstituiranog alkila, supstituiranog alkilena, supstituiranog alkinila, supstituiranog arila, supstituiranog heteroarila, supstituiranog cikloalkila, supstituiranog heterociklila. Patent sadrži još 8 patentnih zahtjeva.A product corresponding to the following formula (I), in which: A-1-Ar is: wherein each X1, X2, X3 and X4 is independently selected from N and CH, wherein A is selected from optionally substituted phenyl, pyrazolyl and isoxazolyl ; L is NH-CO-NH; Ra is H; R1 is H; R2 and R5 are independently selected from the group consisting of: H, halogen, R'2, OR'2, NHR'2, NHCOR'2, NHCONHR'2, NHSO2R'2, wherein each R'2, R ' 3 and R'4 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, substituted alkyl, substituted alkylene, substituted alkynyl, substituted aryl, substituted heteroaryl, substituted cycloalkyl . The patent contains 8 more patent claims.

HR20090158T 2005-02-10 2009-03-17 Substituted pyrroles, compositions containing same, method for making same and use thereof HRP20090158T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (en) 2005-02-10 2005-02-10 SUBSTITUTED PYRROLES, COMPOSITIONS CONTAINING SAME, METHOD OF MANUFACTURE AND USE
PCT/FR2006/000286 WO2006084996A1 (en) 2005-02-10 2006-02-08 Substituted pyrroles, compositions containing same, method for making same and use thereof

Publications (1)

Publication Number Publication Date
HRP20090158T1 true HRP20090158T1 (en) 2009-05-31

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090158T HRP20090158T1 (en) 2005-02-10 2009-03-17 Substituted pyrroles, compositions containing same, method for making same and use thereof

Country Status (36)

Country Link
US (1) US7592365B2 (en)
EP (1) EP1851198B1 (en)
JP (1) JP2008530061A (en)
KR (1) KR20070101317A (en)
CN (1) CN101115716A (en)
AR (1) AR052571A1 (en)
AT (1) ATE419234T1 (en)
AU (1) AU2006212106A1 (en)
BR (1) BRPI0606955A2 (en)
CA (1) CA2596822A1 (en)
CR (1) CR9231A (en)
CY (1) CY1108916T1 (en)
DE (1) DE602006004566D1 (en)
DK (1) DK1851198T3 (en)
DO (1) DOP2006000028A (en)
EA (1) EA013060B1 (en)
ES (1) ES2319926T3 (en)
FR (1) FR2881742B1 (en)
GT (1) GT200600048A (en)
HR (1) HRP20090158T1 (en)
IL (1) IL184488A0 (en)
MA (1) MA29248B1 (en)
MX (1) MX2007008789A (en)
MY (1) MY142082A (en)
NO (1) NO20074528L (en)
PA (1) PA8661601A1 (en)
PE (1) PE20061086A1 (en)
PL (1) PL1851198T3 (en)
PT (1) PT1851198E (en)
RS (1) RS50806B (en)
SI (1) SI1851198T1 (en)
TN (1) TNSN07241A1 (en)
TW (1) TW200640858A (en)
UY (1) UY29371A1 (en)
WO (1) WO2006084996A1 (en)
ZA (1) ZA200706157B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (en) 2005-02-03 2007-03-30 Aventis Pharma Sa SUBSTITUTED PYROLLES AND IMIDAZOLES, COMPOSITIONS CONTAINING THE SAME, PROCESS FOR FRABRICATION AND USE
NZ576291A (en) * 2006-10-23 2011-10-28 Lexicon Pharmaceuticals Inc Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (en) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 Salt of apoptosis signal-regulating kinase 1 inhibitor and crystal form thereof
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
EP1436279B8 (en) * 2001-09-21 2008-10-29 Smithkline Beecham Corporation Chemical compounds
US7307097B2 (en) 2001-09-27 2007-12-11 Smithkline Beechman Corporation Chemical compounds
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
AU2004221881A1 (en) * 2003-03-13 2004-09-30 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (en) 2003-11-19 2005-06-02 Merck Patent Gmbh pyrrole
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (en) 2005-02-03 2007-03-30 Aventis Pharma Sa SUBSTITUTED PYROLLES AND IMIDAZOLES, COMPOSITIONS CONTAINING THE SAME, PROCESS FOR FRABRICATION AND USE

Also Published As

Publication number Publication date
GT200600048A (en) 2006-07-03
CR9231A (en) 2007-10-23
KR20070101317A (en) 2007-10-16
MA29248B1 (en) 2008-02-01
AU2006212106A1 (en) 2006-08-17
RS50806B (en) 2010-08-31
US7592365B2 (en) 2009-09-22
NO20074528L (en) 2007-10-31
SI1851198T1 (en) 2009-06-30
PE20061086A1 (en) 2006-11-30
PT1851198E (en) 2009-03-26
DE602006004566D1 (en) 2009-02-12
ES2319926T3 (en) 2009-05-14
EP1851198A1 (en) 2007-11-07
AR052571A1 (en) 2007-03-21
MY142082A (en) 2010-08-30
JP2008530061A (en) 2008-08-07
PA8661601A1 (en) 2006-09-08
BRPI0606955A2 (en) 2009-07-28
US20080167368A1 (en) 2008-07-10
FR2881742B1 (en) 2007-09-07
WO2006084996A1 (en) 2006-08-17
UY29371A1 (en) 2006-10-02
ATE419234T1 (en) 2009-01-15
MX2007008789A (en) 2007-09-11
IL184488A0 (en) 2007-10-31
DK1851198T3 (en) 2009-05-04
CN101115716A (en) 2008-01-30
EP1851198B1 (en) 2008-12-31
DOP2006000028A (en) 2006-09-15
CY1108916T1 (en) 2014-07-02
EA013060B1 (en) 2010-02-26
ZA200706157B (en) 2008-11-26
TNSN07241A1 (en) 2008-11-21
FR2881742A1 (en) 2006-08-11
TW200640858A (en) 2006-12-01
CA2596822A1 (en) 2006-08-17
EA200701688A1 (en) 2007-12-28
PL1851198T3 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
RS51136B (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
HRP20090158T1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
EA200702002A1 (en) REPLACED DERIVATIVES OF PYRAZOLYLOXYPHENYL, USED AS HERBICIDES
EA200701779A1 (en) DERIVATIVES (1,5-DIPHENYL-1N-PYRAZOL-3-IL) OXADIAZOLE, THEIR RECEIVING AND THEIR USE IN THERAPY
RS53588B1 (en) Compounds and compositions as protein kinase inhibitors
TW200744994A (en) Insecticidal 3-acylaminobenzanilides
EA200601620A1 (en) 5,6-DIALKYL-7-AMINOTRIAZOLOPYRIMIDINES, METHOD OF THEIR RECEIVING AND THEIR APPLICATION FOR COMBATING PATHOGENIC PLANTS, AND ALSO CONTAINING THEM
ATE338461T1 (en) PYRAZOLEPYRIMIDE INFUNGICIDES
ME00615B (en) 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
EA200700185A1 (en) HINAZOLINDION DERIVATIVES AS PARP INHIBITORS
EA201591000A1 (en) Pyrrolobenzodiazepine
EA200700188A1 (en) DERIVATIVES OF SUBSTITUTED 2-ALKYLKHINAZOLINON AS PARP INHIBITORS
HRP20080113T3 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
SE0301373D0 (en) Novel compounds
RS51725B (en) N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
HRP20100624T8 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
CO6160235A2 (en) INSECTICIDE ISOXAZOLINS
HRP20020888B1 (en) Glycopeptide phosphonate derivatives
HUP0402592A2 (en) Phenyl substituted heterocyclic compounds useful as herbicides
MX2011009034A (en) Prodrug forms of kinase inhibitors and their use in therapy.
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
AR044909A1 (en) DERIVATIVES OF THIAZOLILPIPERIDINE, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND APPLICATIONS OF SUCH DERIVATIVES IN THE TREATMENT OF HYPERTRIGLICERIDEMIA, HYPERCHOLESTEROLEMIA AND DISLIPIDEMIA
RS50017B (en) 2-pyridylmethylamine derivatives useful as fungicides
BR0316241A (en) Pyrrolobenzodiazepines
EA201000413A1 (en) Method of producing lactamide derivatives, new lactamide derivatives and preparations containing lactamide derivatives